Gotowa bibliografia na temat „Télésurveillance des dispositifs médicaux”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Télésurveillance des dispositifs médicaux”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Télésurveillance des dispositifs médicaux"
Desire, Amélie, i Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 3, nr 12 (grudzień 2007): 42–48. http://dx.doi.org/10.1016/s1769-7344(07)70019-7.
Pełny tekst źródłaRuault, Céline, i Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, nr 17 (luty 2009): 38. http://dx.doi.org/10.1016/s1769-7344(09)70135-0.
Pełny tekst źródłaCerbelaud, Nadège, i Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, nr 17 (luty 2009): 39–40. http://dx.doi.org/10.1016/s1769-7344(09)70136-2.
Pełny tekst źródłaBrischoux, Sonia. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, nr 17 (luty 2009): 41–42. http://dx.doi.org/10.1016/s1769-7344(09)70137-4.
Pełny tekst źródłaCrickx, B., i X. Arrault. "Dispositifs médicaux implantables". Annales de Dermatologie et de Vénéréologie 135, nr 1 (styczeń 2008): 66–69. http://dx.doi.org/10.1016/s0151-9638(08)70214-x.
Pełny tekst źródłaLetard, J. C. "Les dispositifs médicaux". Acta Endoscopica 33, nr 2 (kwiecień 2003): 269–71. http://dx.doi.org/10.1007/bf03028419.
Pełny tekst źródłaHajjar, Joseph. "Traitement des dispositifs médicaux". Le Praticien en Anesthésie Réanimation 9, nr 6 (grudzień 2005): 482–87. http://dx.doi.org/10.1016/s1279-7960(05)83775-1.
Pełny tekst źródłaTétart, Florence. "Dispositifs médicaux et allergies". Dermato Mag 11, nr 3 (1.06.2023): 181–83. http://dx.doi.org/10.1684/dmg.2023.644.
Pełny tekst źródłaSommer, Johanna, i Martine Bideau. "Dispositifs médicaux moins polluants". Revue Médicale Suisse 20, nr 877 (2024): 1125. http://dx.doi.org/10.53738/revmed.2024.20.877.1125.
Pełny tekst źródłaAncellin, Joël. "La sécurité des dispositifs médicaux". RBM-News 17, nr 4 (styczeń 1995): M5. http://dx.doi.org/10.1016/s0222-0776(00)88939-7.
Pełny tekst źródłaRozprawy doktorskie na temat "Télésurveillance des dispositifs médicaux"
Chehbani, Amel. "Etude et mise en œuvre d’un système communicant sans fil et sans radio pour la mesure de paramètres physiologiques des nouveau-nés". Electronic Thesis or Diss., Limoges, 2024. http://www.theses.fr/2024LIMO0009.
Pełny tekst źródłaThe weak immune systems in the elderly, newborns and preterm infants increase their susceptibility to cardiovascular disease and heart failure. Indeed, symptoms of cardiac pathology can be quite unusual and sporadic in this population. This requires continuous monitoring of cardiac activity by electrocardiogram (ECG), which enables early detection of abnormalities. Conventionally, ECG systems are wired, limiting continuous monitoring and patient comfort. Thanks to technology, portable and wireless ECG systems have also been developed, based mainly on efficient radio frequency (RF) technologies, which enable these users to be monitored regularly. However, security and privacy requirements, interference generation, potential harmful effects on patient health, spectrum congestion and energy efficiency are challenges for the massive deployment of RF technologies in healthcare scenarios. Instead of relying on the limitations of RF systems, this thesis focuses on an alternative solution based on optical wireless technologies that enable safe and environmentally-friendly communications. This solution consists of a monitoring system using an infrared link between a transmitter embedded in an ECG sensor placed on the user's body and receivers placed on the ceiling of the environment. In order to study the three monitoring contexts, the corresponding optical channel was simulated using a ray-tracing technique combined with the numerical Monte-Carlo method. Considering the specificities of the monitoring scenario, the population (age and mobility) and the modeled environment (transparent material of premature baby incubators), the static gain characterizing the channel was obtained. This gain was used in a chain developed to simulate ECG transmission in each context. The reliability of the proposed remote monitoring system is thus conditioned by the quality of the transmitted ECG signal. This has been assessed at application level using the Signal Quality Index (SQI) method, which consists in extracting spectral and statistical characteristics from the ECG. In addition, given its usefulness in monitoring the development of premature infants, heart rate variability (HRV) has also been analyzed by computing the temporal parameters that characterize RR intervals in an ECG. The main objective is to assess the impact of time-varying optical transmission performance on the quality of the received ECG signal, in order to design a less intrusive, reliable and cost-effective system for remote ECG signal monitoring. SQIs consist in extracting spectral and statistical characteristics from the ECG. In addition, given its usefulness in monitoring the development of premature infants, heart rate variability (HRV) was also analyzed by computing the temporal parameters that characterize RR intervals. The main objective is to assess the impact of optical transmission performance on ECG quality metrics. For this purpose, a general analysis approach was implemented to jointly study the evolution of (SQIs) and VFC temporal parameters at the application level as a function of classical metrics at the physical level, namely (SNR) and (BER). The results of this research showed the potential of using wireless optics in such medical contexts to provide a reliable and energy-efficient solution. Indeed, in all three cases investigated, ECG signals of sufficient quality for reliable diagnoses were obtained at moderate levels of transmitted optical power, which is important for a portable medical remote monitoring system
Leroy, Sylvie. "Traçabilité informatique des dispositifs médicaux implantables : création du logiciel "VIGIPHARM R version dispositifs médicaux"". Paris 5, 1997. http://www.theses.fr/1997PA05P199.
Pełny tekst źródłaHuot, Laure. "Evaluation clinique des dispositifs médicaux". Phd thesis, Université Claude Bernard - Lyon I, 2012. http://tel.archives-ouvertes.fr/tel-00983482.
Pełny tekst źródłaNeveu, David. "La normalisation des dispositifs médicaux". Bordeaux 2, 1997. http://www.theses.fr/1997BOR2P105.
Pełny tekst źródłaLe, Moual Sylvie. "Assurance qualité des dispositifs médicaux". Paris 5, 1992. http://www.theses.fr/1992PA05P248.
Pełny tekst źródłaAbed, Aïcha. "Nouveaux dispositifs médicaux à base d'hydrogels de polysaccharides". Paris 13, 2012. http://www.theses.fr/2012PA132062.
Pełny tekst źródłaThis work describes the development of new medical devices based on hydrogel of polysaccharides (pullulan and dextran). In recent years, our laboratory was interested in the biological properties of synthetic or natural polysaccharides and their interactions with endogenous growth factors and matrix components. So we had the idea to apply their properties to the design of a hybrid material composed of a polypropylene mesh coated with polysaccharides hydrogel. The first objective of this work is to improve the integration of materials currently used in clinical by using of hybrid prosthesis and understand the properties of these hydrogels in vitro and in vivo. In the second part of this work, based on the hydrogel properties a new system of storage and transport of tissue at room temperature was developed while limiting mechanical shocks and contamination associated with leaking fluids. Taking as a model of rat arteries, we validated this system in vitro and in vivo. Finally, we developed a new system for cryopreservation of cells and tissues. This hydrogel based polysaccharides reduces the quantities of toxic cryoprotectants agents during freezing. This method was validated in vitro and in vivo and in comparison with the reference procedure
Lamarche, Juliette. "Les dispositifs médicaux non réutilisables de circulation extra-corporelle". Paris 5, 1997. http://www.theses.fr/1997PA05P148.
Pełny tekst źródłaMaho, Thomas. "Stérilisation de dispositifs médicaux ensachés par plasmas froids basse pression". Thesis, Orléans, 2016. http://www.theses.fr/2016ORLE2077.
Pełny tekst źródłaStandard sterilization methods such as autoclave, ethylene oxide or irradiation can affect the biocompatibility of medical devices, especially those sensitive to heat or chemicals products. Numerous studies have demonstrated the possibility to use low pressure plasmas as an alternative sterilization process: low process temperature, treatment time competitive to autoclave and without any toxic agent. However, the sterile state preservation is still a problem. In the framework of the ANR PLAS'STER project, this CIFRE thesis focus on a new sterilization process development based on low pressure cold plasmas. The innovation resides in the creation and the confinement of a plasma inside a sterilization bag, thereby ensuring the conservation of the sterile state. The first part was dedicated to the physical characterization of the plasmas discharges confined inside the bag of sterilization. Secondly, the bactericidal efficiency of the process was demonstrated on Gram negative and Gram positive bacteria according to the EN556 standard. Additional tests on E. coli lead to hypothesis on the sterilization mechanisms and opened tracks on the optimization of our process. Finally, the properties analysis of biomaterials demonstrated the absence of macromolecular modifications and validated the potentiality of the process PLAS' STER as the sterilization method alternative
Ethgen, Bonnet Morgane. "Méthodes d'évaluation des traitements non pharmacologiques : l'exemple des dispositifs médicaux implantables". Paris 6, 2012. http://www.theses.fr/2012PA066184.
Pełny tekst źródłaOur first study was to compare the reporting f harm in trials of pharmacologic (PT) and nonpharmacologic treatment (NPT). 193 articles were analysed. After adjustement for medical areas, sample size, funding source, and multicenter trails, data on harm were more often described in PT reports than in NPT reports in reporting dverse events. The lack of reporting harm in trials assessing NPT in rheuatic disease is an important barrier to evaluating the benefit-harm balance of NPT. Our second work evaluated the harm reporting and the quality of internal and external validity in published reports evaluating the stent for percutaneous coronary intervention. 132 articles were analyzed. The volume of interventions per center was described in 2 reports, and in 5 reports for operator expertise. The generation of allocation sequence was adequate in 58. 3%, treatment allocation was concealed in 34. 8%. Several harm related data were not adequately accounted for in articles and the current reprting of results of RCTs testing stents needs to be improved to allow readers to appraise the risk of biais and the applicability of results
Folefack, Ernest. "Recherches sur le droit international des médicaments et des dispositifs médicaux". Bordeaux 4, 1998. http://www.theses.fr/1998BOR40034.
Pełny tekst źródłaThe objective of the author is prouve the existence of international law rules regulating the movement of drugs and medical devices in the international market. These rules are mainly produced by international organisations with competence on health either on the universal basis (see who) or regional basis (eu or the european council). Thesis rules have strong links with technical regulation such as standard. Theses rules have public health purposes since they are aimed at maintaining the quality of drugs and medical devices as regard safety of patients. They are imposed at all stages of the production of drugs from the conception (international and national pharmacopoeia, glp), the stage of manufacturing (gmp) the respect of legal and ethical rules concerning the testing of new drugs on human being (gcp), the harmonisation of new drugs registration procedures, the rational use of drugs and medical devices based on adequates information, restriction of publicity and an overrall worldwide monitoring of the use of drugs and medical devices. But a global international legal coherent system of regulation of drugs and medical devices is yet to be consolidated
Książki na temat "Télésurveillance des dispositifs médicaux"
normalisation, Association française de. Stérilisation des dispositifs médicaux. Saint-Denis La Plaine: AFNOR, 2004.
Znajdź pełny tekst źródłaWorld Health Organization (WHO). Dons de dispositifs médicaux: Considérations relatives à leur demande et à leur attribution. Switzerland: World Health Organization, 2012.
Znajdź pełny tekst źródłaLaval, Guillemette. Soins palliatifs: Les principales thérapeutiques en soins palliatifs chez l'adulte et la personne âgée : médicaments, dispositifs médicaux, prescriptions de sortie. Wyd. 3. Montpellier: Sauramps médical, 2006.
Znajdź pełny tekst źródłaStérilisation des dispositifs médicaux. Paris: AFNOR, 1999.
Znajdź pełny tekst źródłaWorld Health Organization (WHO). Package Série Technique de l'OMS Sur les Dispositifs Médicaux. World Health Organization, 2012.
Znajdź pełny tekst źródłaWorld Health Organization (WHO). Liste interinstitutions de dispositifs médicaux prioritaires pour des interventions essentielles: En santé reproductive, maternelle, néonatale et infantile. World Health Organization, 2017.
Znajdź pełny tekst źródłaMABANZA, Tryphon. Incidents Critiques d'une Machine d'anesthÉsie Clinique Hier et AUJOURD'HUI: Une Introduction Aux Normes des Dispositifs Médicaux et des Stratégies Efficaces Pour Son Contrôle d'assurance Qualité Quotidien et Régulier. Independently Published, 2021.
Znajdź pełny tekst źródłaCzęści książek na temat "Télésurveillance des dispositifs médicaux"
Gaillard, C., A. Capelle i X. Armoiry. "Dispositifs médicaux en oncologie". W Pharmacie Clinique Pratique en Oncologie, 82–94. Elsevier, 2020. http://dx.doi.org/10.1016/b978-2-294-76375-5.00010-5.
Pełny tekst źródłaCallanquin, J., C. Camuzeaux i P. Labrude. "Dispositifs Médicaux et Matériovigilance". W Le matériel de maintien à domicile, 15–32. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-08853-7.50002-2.
Pełny tekst źródłaGaillard, Claire, i Daniel Hartmann. "Biocompatibilité des dispositifs médicaux". W Pharmacie clinique et dispositifs médicaux, 51–55. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00008-9.
Pełny tekst źródłaGhislain, Jean-Claude. "Approche réglementaire des dispositifs médicaux". W Pharmacie clinique et dispositifs médicaux, 13–16. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00002-8.
Pełny tekst źródłaCabelguenne, Delphine, Pierre Cassier, El-Mahdi Hafiani, Vincent Létoublon, Marie Selvy i Valérie Sautou. "Dispositifs médicaux et développement durable". W Pharmacie clinique et dispositifs médicaux, 91–96. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00014-4.
Pełny tekst źródłaSalomez-Ihl, Cordélia, Rémy Collomp, Alexandre Moreau-Gaudry i Pierrick Bedouch. "e-santé et dispositifs médicaux". W Pharmacie clinique et dispositifs médicaux, 327–41. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00036-3.
Pełny tekst źródłaGaillard, Claire, Daniel Hartmann i Yves François. "Les dispositifs médicaux en stomathérapie". W Pharmacie clinique et dispositifs médicaux, 233–38. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00026-0.
Pełny tekst źródłaChambrin, Pierre-Yves, i Gilles Aulagner. "Évaluation clinique des dispositifs médicaux". W Pharmacie clinique et dispositifs médicaux, 17–20. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00003-x.
Pełny tekst źródłaGoeury, Dominique, Gilles Aulagner, Olivier Claris i Frédérique Perlier. "Le retraitement des dispositifs médicaux à usage unique". W Pharmacie clinique et dispositifs médicaux, 79–84. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00012-0.
Pełny tekst źródłaCabelguenne, Delphine, Damien Royané, Vincent Piriou i Stéphanie Genay. "Principes de la perfusion médicamenteuse et dispositifs médicaux utilisés en perfusion intraveineuse". W Pharmacie clinique et dispositifs médicaux, 99–111. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00015-6.
Pełny tekst źródłaStreszczenia konferencji na temat "Télésurveillance des dispositifs médicaux"
Danet, C., V. Duhalde, A. Culetto, K. Barange, L. Buscail, C. Barrué, I. Labadens i P. Cestac. "Comment informer les professionnels de santé sur les Dispositifs Médicaux? Création en endoscopie digestive d'un outil pilote informatique connecté au livret des Dispositifs Médicaux de l'hôpital". W Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680970.
Pełny tekst źródła